JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-1.79 Cr | ₹3.24 Cr | ₹0.47 Cr | ₹-1.37 Cr | ₹2.54 Cr |
What is the latest Net Cash Inflow / Outflow ratio of JENBURKT PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-1.79 Cr |
| Mar2025 | ₹3.24 Cr |
| Mar2024 | ₹0.47 Cr |
| Mar2023 | ₹-1.37 Cr |
| Mar2022 | ₹2.54 Cr |
How is Net Cash Inflow / Outflow of JENBURKT PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1.79 Cr | Negative | |
| Mar2025 | ₹3.24 Cr | 596.56 | |
| Mar2024 | ₹0.47 Cr | Positive | |
| Mar2023 | ₹-1.37 Cr | Negative | |
| Mar2022 | ₹2.54 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹422.3 Cr | 8.4% | 9.4% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 8.4% |
9.4% |
-25.9% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses